James Fagin

25PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 12, 2025
Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.

Justin Choi, Eric Sherman, Edward Christopher Dee

|Feb 24, 2025
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.

Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch

|Jan 06, 2025
High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome.

Daniel W Scholfield, Bin Xu, Helena Levyn

|Oct 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis.

Vera Tiedje, Pablo Sánchez Vela, Julie L Yang

|Aug 16, 2024
Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors.

Aradhya Nigam, Gnana P Krishnamoorthy, Walid K Chatila

|Jul 19, 2024
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.

Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch

Pageof 5